Superantigens for the receptors of B lymphocytes that have properties akin to known superantigens for T-cells have only recently been identified. The current program is designed to investigate the immune modulatory properties of a bacterial membrane protein, that the investigator discovered has the structural and functional properties of a B-cell superantigen. The investigator s lab has have demonstrated that Staphylococcal protein A (SpA) has sites that enable variable region-mediated binding by more than 10% of human B-cells, and most (and perhaps all) functional germline gene segments for the VH clan III can encode for Fab-mediated binding of SpA. Recent observations also provide experimental evidence that in vivo exposure to SpA can result in positive selection of the 'primary' B-cell repertoire. To extend these investigations of this model B-cell superantigen, The application proposes to: i) evaluate the structural basis of SpA binding and identify potential contact sites at the molecular level following in vitro expression of immunoglobulins encoded by human and murine VH genes in bacterial and mammalian cells; ii) use murine immunization models to investigate the in vivo capacity for SpA to selectively influence VH-based clonal expansion, deletion and/or anergy within the peripheral B-cell compartment; iii) to investigate the distribution, phenotype and V gene expression of B-cell precursors in the central compartment of SpA-immunized mice to look for evidence of superantigen-induced positive and negative clonal selection; and iv) to evaluate whether this model superantigen is capable of VH-mediated interactions with the m/surrogate light chain membrane complexes of transformed preB-cell lines that express defined VH regions. A long-term goal of these studies is to evaluate the feasibility of using B-cell superantigens in clinically relevant therapies that include the down regulation of disease-associated autoimmune B-cell clones and the augmentation of protective immune responses against infectious pathogens.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI040305-04
Application #
6373554
Study Section
Immunobiology Study Section (IMB)
Program Officer
Johnson, David R
Project Start
1998-05-01
Project End
2003-04-30
Budget Start
2001-05-01
Budget End
2002-04-30
Support Year
4
Fiscal Year
2001
Total Cost
$251,785
Indirect Cost
Name
University of California San Diego
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Pelzek, Adam J; Grönwall, Caroline; Rosenthal, Pamela et al. (2017) Persistence of Disease-Associated Anti-Citrullinated Protein Antibody-Expressing Memory B Cells in Rheumatoid Arthritis in Clinical Remission. Arthritis Rheumatol 69:1176-1186
Frost, Simon D W; Murrell, Ben; Hossain, A S Md Mukarram et al. (2015) Assigning and visualizing germline genes in antibody repertoires. Philos Trans R Soc Lond B Biol Sci 370:
Grönwall, Caroline; Kosakovsky Pond, Sergei L; Young, Jason A et al. (2012) In vivo VL-targeted microbial superantigen induced global shifts in the B cell repertoire. J Immunol 189:850-9
Bartok, Beatrix; Silverman, Gregg J (2011) Development of anti-CD20 therapy for multiple sclerosis. Exp Cell Res 317:1312-8
MacLellan, Lindsay M; Montgomery, Jennifer; Sugiyama, Fujimi et al. (2011) Co-opting endogenous immunoglobulin for the regulation of inflammation and osteoclastogenesis in humans and mice. Arthritis Rheum 63:3897-907
Becker-Herman, Shirly; Meyer-Bahlburg, Almut; Schwartz, Marc A et al. (2011) WASp-deficient B cells play a critical, cell-intrinsic role in triggering autoimmunity. J Exp Med 208:2033-42
Chen, Yifang; Khanna, Sahil; Goodyear, Carl S et al. (2009) Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis. J Immunol 183:1346-59
Chen, Yifang; Park, Yong-Beom; Patel, Ekta et al. (2009) IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells. J Immunol 182:6031-43
Silverman, G J; Srikrishnan, R; Germar, K et al. (2008) Genetic imprinting of autoantibody repertoires in systemic lupus erythematosus patients. Clin Exp Immunol 153:102-16
Silverman, Gregg J; Boyle, David L (2008) Understanding the mechanistic basis in rheumatoid arthritis for clinical response to anti-CD20 therapy: the B-cell roadblock hypothesis. Immunol Rev 223:175-85

Showing the most recent 10 out of 38 publications